Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-14-059001
Filing Date
2014-10-01
Accepted
2014-10-01 16:00:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 v390431_s3.htm S-3 290424
2 EXHIBIT 4.2 v390431_ex4-2.htm EX-4.2 593253
3 EXHIBIT 4.3 v390431_ex4-3.htm EX-4.3 633239
4 EXHIBIT 5.1 v390431_ex5-1.htm EX-5.1 28216
5 EXHIBIT 23.1 v390431_ex23-1.htm EX-23.1 1553
  Complete submission text file 0001144204-14-059001.txt   1547734
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-199093 | Film No.: 141133017
SIC: 2834 Pharmaceutical Preparations